Italian paediatricians and off-label prescriptions: Loyal to regulatory or guideline standards?

Acta Paediatrica, International Journal of Paediatrics

Volumn 94, Issue 6, 2005, Pages 753-757

  Pandolfini, Chiara ^a   Campi, Rita ^a   Clavenna, Antonio ^a   Cazzato, Teresa ^b   Bonati, Maurizio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b ASL TA/1   (Italy)

Author keywords

Drug; Drug labelling; Guidelines; Paediatrics; Prescriptions; Primary healthcare

Indexed keywords

AMBROXOL; ANALGESIC AGENT; ANTIPYRETIC ANALGESIC AGENT; CEPHALOSPORIN DERIVATIVE; FLURBIPROFEN; MORNIFLUMATE; NIFLUMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE;

ARTICLE; DRUG LABELING; GENERAL PRACTICE; HUMAN; ITALY; PEDIATRICIAN; PEDIATRICS; PHARYNGITIS; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; STANDARD; TONSILLITIS;

CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; ITALY; PEDIATRICS; PHARYNGITIS; PRESCRIPTIONS, DRUG; PRODUCT LABELING; TONSILLITIS;

EID: 20544441298     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/0803525051002948     Document Type: Article

References (30)

1. Pandolfini C, Bonati M. Off-label drug use in children in Europe: a major health issue. Pharm Dev Regul 2003;1: 133-43.
2. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. Br Med J 2000; 320:79-82.
3. Cuzzolin L, Zaccaron A, Fanos V. Unlicensed and off-label uses of drugs in paediatrics: a review of the literature. Fundam Clin Pharmacol 2003;17:125-31.
4. Conroy S. Unlicensed and off-label drug use: issues and recommendations. Paediatr Drugs 2002;4:353-9.
5. Schirm E, Tobi H, de Vries TW, Choonara I, De Jong-van den Berg LT. Lack of appropriate formulations of medicines for children in the community. Acta Paediatr 2003; 92:1486-9.
6. Caldwell PH, Murphy SB, Butow PN, Craig JC. Clinical trials in children. Lancet 2004;364:803-11.
7. Choonara I, Conroy S. Unlicensed and off-label drug use in children: implications for safety. Drug Saf 2002;25:1-5.
8. Nunn AJ. Making medicines that children can take. Arch Dis Child 2003;88:369-71.
9. Ufer M, Kimland E, Bergman U. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf 2004;13:147-52.
10. Cazzato T, Pandolfini C, Campi R, Bonati M, ACP Puglia-Basilicata Working Group. Drug prescribing in Italian outpatient children in Southern Italy. Eur J Clin Pharmacol 2001;57:611-6.
11. Management of sore throat and indications for tonsillectormy. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1999.
12. Pharyngitis. Guidelines for clinical care. Ann Arbor (MI): University of Michigan Health System; 2000.
13. Acute pharyngitis. Bloomington (MN): Institute for Clinical Systems Improvement; 1999 July; 2004.
14. The diagnosis and treatment of acute pharyngitis. Edmonton (Alberta): Alberta Clinical Practice Guidelines Program; 1999 July; 2004.
15. Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2004; 35:113-25.
16. Hanna K, Poulin-Costello M, Preston M, Maresky N. Intravenous immune globulin use in Canada. Can J Clin Pharmacol 2003;10:11-6.
17. Lifshitz M, Gavrilov V, Grossman Z, Binsthok M, Hornik D, Rosemblum H, et al. Unapproved prescription practices in primary pediatric clinics in Israel: A prospective analysis. Curr Ther Res Clin Exp 2002;63:830-7.
18. Riordan FA. Use of unlabelled and off license drugs in children. Use of unlicensed drugs may be recommended in guidelines. Br Med J 2000;320:1210.
19. Thompson DF, Heflin NR. Frequency and appropriateness of drug prescribing for unlabeled uses in pediatric patients. Am Journal Hosp Pharm 1987;44:792-4.
20. Thouvenel C, Geny MS, Demirdjian S, Vassal G. Statutory pediatric information available for anticancer drugs: inventory and proposals. Arch Pediatr 2002;9:685-93.
21. Ufer M, Rane A, Karlsson A, Kimland E, Bergman U. Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm. Eur J Clin Pharmacol 2003;58:779-83.
22. Bonati M, Clavenna A, Rocchi F, Impicciatore P. Use of niflumic acid in children. Arch Dis Child 2004; URL: http:// adc.bmjjournals.com/cgi/eletters/84/ 5/430.
23. Menniti-Ippolito F, Sagliocca L, Da CR, Saggiomo G, Di NR, Traversa G. Niflumic acid and cutaneous reactions in children. Arch Dis Child 2001;84:430-1.
24. Kozyrskyj AL, Dahl ME, Chateau DG, Mazowita GB, Klassen TP, Law BJ. Evidence-based prescribing of antibiotics for children: role of socioeconomic status and physician characteristics. CMAJ 2004;171:139-45.
25. Casey JR, Pichichero ME. Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics 2004;113:866-82.
26. Shulman ST, Gerber MA. So what's wrong with penicillin for strep throat? Pediatrics 2004;113:1816-9.
27. Matsui DM, Jardine ME, Steer E, Cukernik V, Rieder MJ. Where physicians look for information on drug prescribing for children. Paediatr Child Health 2003;8:219-21.
28. Clavenna A, Bonati M. Una "Dear Doctor Letter" per razionalizzare l'uso dei farmaci antinfiammatori non steroidei (FANS) nei bambini. G Ital Farm Clin 2001;15:36-7.
29. Clavenna A, Rossi E, Berti A, Pedrazzi G, De Rosa M, Bonati M. Inappropriate use of anti-asthmatic drugs in the Italian paediatric population. Eur J Clin Pharmacol 2003;59:565-9.
30. Dickersin K, Rennie D. Registering clinical trials. JAMA 2003;290:516-23.